ABC | Volume 113, Nº2, Agosto 2019

Correlação Anatomoclínica Pinesi et al. Homem de 26 anos com doença de chagas congênita e transplante cardíaco Arq Bras Cardiol. 2019; 113(2):286-293 Figura 10 – Fotomicrografia de corte histológico da biópsia endomiocárdica, submetido a reação de imuno-histoquímica para parasitas do T.cruzi. Nota-se, em castanho, ninhos de amastigotas do parasita (setas). Contracoloração com hematoxilina de Harris, aumento da objetiva= 40X. 1. ChagasC.Novatripanozomiasehumana.Estudossobreamorfologiaeociclo evolutivo do Schizotrypanum cruzi, n. gen., n. s, agente etiológico de nova entidade morbida do homem. Mem Inst Oswaldo Cruz. 1909; 1(2):11-62. 2. Dias JC. SouthernCone Initiative for the elimination of domestic populations of Triatoma infestans and the interruption of transfusion Chagas disease: historical aspects, present situation, and perspectives. Mem Inst Oswaldo Cruz. 2007; 102(suppl. 1):s11-s18. 3. Moncayo A, Silveira AC. Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Mem Inst Oswaldo Cruz. 2009; 104(4):17-30. 4. Xavier SC, Roque AL, BilacD. Distantiae transmission of Trypanosoma cruzi: a new epidemiological feature of acute Chagas disease in Brazil. PLoS Negl Trop Dis. 2014; 8(5):e2878. 5. World Health Organization.(WHO). Chagas disease: control and elimination. Geneva,2010 (A63-17 1-4- World Health Assembly Report.) 6. Martins-Melo FR, Ramos AN, Jr., Alencar CH, Heukelbach J. Prevalence of Chagas disease in Brazil: a systematic review and meta-analysis. Acta Trop. 2014; 130:167-74. 7. Andrade JP, Marin Neto JA, Paola AA. I Latin American Guidelines for the diagnosis and treatment of Chagas’ heart disease: executive summary. Arq Bras Cardiol. 2011; 96(6):434-42. 8. Teixeira MM, Gazzinelli RT, Silva JS. Chemokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol. 2002; 18(6):262-5. 9. Cunha-Neto E, Bilate AM, Hyland KV, Fonseca SG, Kalil J, Engman DM. Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry. Autoimmunity. 2006; 39(1):41-54. 10. Martins-Melo FR, Lima Mda S, Ramos AN Jr, Alencar CH, Heukelbach J. Prevalence of Chagas disease in pregnant women and congenital transmission of Trypanosoma cruzi in Brazil: a systematic review and meta- analysis. Tropical Med Int Health. 2014;19:943–57 11. Fabbro DL, Danesi E, Olivera V, Codebó MO, Denner S, Heredia C, et al. Trypanocide treatment of women infected with Trypanosoma cruzi and its effect on preventing congenital Chagas. PLoS Negl Trop Dis. 2014;8(11): e3312. 12. Moya P, Basso B, Moretti E, “Congenital Chagas disease in Córdoba, Argentina: epidemiological, clinical, diagnostic, and therapeutic aspects. Experience of 30 years of follow up,” Revista da Sociedade Brasileira de Medicina Tropical.2005;38(supl2):33-40. 13. Cevallos AM, Hernández R. Chagas’ Disease: Pregnancy and Congenital Transmission. BioMed Res Int. 2014; vol.2014, Article ID401864 10 pages. 14. Dias JCP, Ramos Jr. AN, Gontijo ED, Luquetti A, Shikanai-YasudaMA, Coura JR et al. II Consenso Brasileiro emDoença de Chagas, 2015. Epidemiol Serv Saúde  . 2016  Jun; 25: 7-86.  15. Bacal F, Marcondes-Braga FG, Rohde LEP, Xavier Júnior JL, de Souza Brito F, Moura LZ,Sociedade Brasileira de Cardiologia. 3ª Diretriz Brasileira de Transplante Cardíaco. Arq Bras Cardiol. 2018; 111(2):230-89. 16. Nogueira SS, Felizardo AA, Caldas IS, Gonçalves RV, Novaes RD. Challenges of immunosuppressive and antitrypanosomal drug therapy after heart transplantation in patients with chronic Chagas disease: a systematic review of clinical recommendations, Transplant Rev.2018;32(3):157-67. 17. Bacal F, Silva CP, Bocchi EA, Pires PV, Moreira LFP, Issa VS, et al. Mychophenolate mofetil increased Chagas Disease reactivation in heart transplanted patients: comparison between two different protocols. Am J Trans 2005; 5. 2017-21. 18. Stewart S, Winters GL, Fishbein MC, Tazelaar HD, Kobashigawa J, Abrams J, et al. Revision of the 1990 working formulationfor the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant. 2005;24(11):1710-20. 19. Campos SV, Strabelli TM, Amato Neto V, Silva CP, Bacal F, Bocchi EA, et al. Risk factors for Chagas’ disease reactivation after heart transplantation. J Heart Lung Transplant. 2008;27(6):597-602. Referências Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 293